Highly Effective xMAP Multiplex Assay for the Detection and Identification of Hemorrhagic Fever Agents, Including Ebola Virus

Developed has been the oligonucleotide liquid biochip based on xMAP technology, designed for the laboratory detection of particularly dangerous viral pathogens such as Ebola and Marburg filoviruses, and Machupo , Junin, and Lassa arenaviruses. The suggested approach allows for the detection of up to 100 viral genome equivalents in a sample. The sensitivity and specificity of oligonucleotide biochip is 100 % when the laboratory panels of positive and negative samples are used. These results indicate that the xMAP multiplexing for the detection and identification of tropical hemorrhagic fever agents, including Ebola virus, is not inferior to the conventional method such as real-time RT-PCR and can be applied for evaluation of viral load, and further on can easily be expanded for both the analysis of new viral agents and for the detection of critical mutations in viral genomes.

xMAP, филовирусы, Эбола, Марбург, аренавирусы, Ласса, Хунин, Мачупо, ПЦР, filoviridae, Ebola, Marburg, arenaviruses, Lassa, Junin, Machupo, PCR

1. Rudzevich T.N., Ternovoy V.A., Kazachinskaya E.I., Razumov I.A., Chepurnov A.A., Loktev V.B., Netesov S.V. [Detection of antigen determinants at N-terminus of Ebola virus VP35 protein, using short recombinant fragments of this protein]. Mol. Gen. Mikrobiol. Virusol. 2003; 2:38–41.

2. Chepurnov A.A., Ternovoy V.A., Dadaneva A.A., Dmitriev I.P., Sizikova L.P., Volchkov V.E., Kudoyarova N.M., Rudzevich T.N., Netesov S.V. [Immunobiological properties of Ebola virus VP24 protein, expressed in recombinant vaccinia virus]. Vopr. Virusol. 1997; 42(3):115–20.

3. Ambrosio A., Saavedra M., Mariani M., Gamboa G., Maiza A. Argentine hemorrhagic fever vaccines. Hum. Vaccin. 2011; 7:694–700.

4. Charrel R.N., de Lamballerie X. Zoonotic aspects of arenavirus infections. Vet. Microbiol. 2010; 140:213–20.

5. Chepurnov A.A., Ternovoy V.A., Tuzova M.N., Chernukhin I.V. Suppressive effect of Ebola virus on T cell proliferation in vitro is provided by a 125-kDa GP viral protein. Immunology Lett. 1999; 68:257–61.

6. Hastie K.M., Kimberlin C.R., Zandonatti M.A., MacRae I.J., Saphire E.O. Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 39 to 59 exonuclease activity essential for immune suppression. Proc. Nat. Acad. Sci USA. 2011; 108:2396–01.

7. Irizarry R.A., Bolstad B.M., Collin F., Cope L.M., Hobbs B., Speed T.P. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003; 31(4):e15.

8. Keller K.L., Iannone M.A. Multiplexed microspherebased flow cytometric assays. Exp. Hematol. 2002; 30:1227–37.

9. Moraz M.L., Kunz S. Pathogenesis of arenavirus hemorrhagic fevers. Expert Rev. Anti Infect. Ther. 2011; 9(1):49–59.

10. Racsa L.D., Kraft C.S., Olinger G.G., Hensley L.E. Viral Hemorrhagic Fever Diagnostics. Clin Infect Dis. 2015, DOI: 10.1093/cid/civ792.

11. Sanchez A., Geisbert T.W., Feldmann H. Filoviridae: Marburg and Ebola viruses. In: Knipe DM, Howley PM, eds. Fields virology. Philadelphia: Lippincott Williams & Wilkins; 2006. P. 1409–48.

12. Volchkov V.E., Becker S., Volchkova V.A., Ternovoj V.A., Kotov A.N., Netesov S.V., Klenk H.D. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology. 1995; 214:421–30.

13. Volchkov V.E., Chepurnov A.A., Volchkova V.A., Ternovoj V.A., Klenk H.-D. Molecular characterization of guinea pig-adapted variants of Ebola virus. Virology. 2000; 277:147–55.

14. Wu Z., Irizarry R.A., Gentleman R., Martinez M.F. A model based background adjustment for oligonucleotide expression arrays. J. Am. Stat. Assoc. 2004; 99:909–17.

15. Wood W.I., Gitschier J., Lasky L.A., Lawn R.M. Base compositionindependent hybridization in tetramethylammonium chloride: a method for oligonucleotide screening of highly complex gene libraries. Proc. Natl. Acad. Sci USA. 198; 2(6):1585–88.